Fox Run Management L.L.C. acquired a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,495 shares of the medical research company’s stock, valued at approximately $470,000.
Other institutional investors have also modified their holdings of the company. KLP Kapitalforvaltning AS purchased a new position in Agilent Technologies in the fourth quarter valued at approximately $13,569,000. Mizuho Securities USA LLC grew its position in shares of Agilent Technologies by 43.9% in the 4th quarter. Mizuho Securities USA LLC now owns 27,232 shares of the medical research company’s stock valued at $3,658,000 after buying an additional 8,313 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Agilent Technologies in the 4th quarter valued at $2,038,000. Lee Danner & Bass Inc. acquired a new stake in Agilent Technologies during the 4th quarter worth $29,000. Finally, Northwest & Ethical Investments L.P. lifted its position in Agilent Technologies by 5.6% in the fourth quarter. Northwest & Ethical Investments L.P. now owns 338,019 shares of the medical research company’s stock valued at $45,409,000 after acquiring an additional 18,038 shares during the last quarter.
Insiders Place Their Bets
In related news, VP Rodney Gonsalves sold 1,908 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. This represents a 8.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The disclosure for this sale can be found here.
Analyst Ratings Changes
Get Our Latest Analysis on Agilent Technologies
Agilent Technologies Trading Down 1.3 %
NYSE:A opened at $120.35 on Wednesday. Agilent Technologies, Inc. has a 1 year low of $117.17 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The stock has a fifty day moving average price of $135.88 and a two-hundred day moving average price of $137.05. The stock has a market capitalization of $34.31 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 3.39 and a beta of 1.11.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.
Agilent Technologies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.82%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.76%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Airline Stocks – Top Airline Stocks to Buy Now
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What Are Dividend Champions? How to Invest in the Champions
- NVIDIA Insiders Sell: This Is What It Means for the Market
- How to Profit From Growth Investing
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.